Ad
The second Covid-19 vaccine produced by the US firm Moderna could be approved sometime this week (Photo: Département des Yvelines)

EU Commission pushes back on 'slow' vaccine roll-out

The EU Commission on Monday (4 January) pushed back against criticism that it acquired too few vaccines, causing delays in the roll-out of the anti-Covid-19 jabs in European countries.

The EU executive said it signed six contracts with companies working on vaccines, for two billion doses, in recent months - amid uncertainties which vaccine would be ready and approved first.

Currently, the Pfizer-BioNTech vaccine is the only one authorised in the EU.

The EU agency, the Eur...

Get EU news that matters

Back our independent journalism by becoming a supporting member

Already a member? Login here

Author Bio

Eszter Zalan is a Hungarian journalist who worked for Brussels-based news portal EUobserver specialising in European politics, focusing on populism and Brexit.

The second Covid-19 vaccine produced by the US firm Moderna could be approved sometime this week (Photo: Département des Yvelines)

Tags

Author Bio

Eszter Zalan is a Hungarian journalist who worked for Brussels-based news portal EUobserver specialising in European politics, focusing on populism and Brexit.

Ad

Related articles

Ad
Ad